Summary
Nineteen pregnant women with uncomplicated pregnancies were studied during the first, second, and third trimesters. We measured the following hemostatic parameters: prothrombin time, activated partial thromboplastin time, fibrinogen, antithrombin III, protein C, protein S, platelet number and volume. Platelet function was examined by a cytofluorimetric method, using an anti-GPM-140 antibody which is directed against a platelet α granule membrane protein. Activated platelets were expressed as a percentage of the GMP-140-positive platelets over total platelets. Fibrinogen levels showed a steady increase during pregnancy; conversely prothrombin time, activated partial thromboplastin time, protein C, and antithrombin III showed no significant modifications and remained within the reference range. There was a decrease of protein S activity throughout pregnancy, although protein S antigen did not follow this trend. The decrease occurred early in pregnancy and persisted during the second and third trimesters, reaching a stable plateau. We observed no platelet volume change or activation: the percentage of activated platelets was within the normal reference range, even in late pregnancy.
Similar content being viewed by others
References
Joist JH. Hypercoagulability: introduction and perspective. Semin Thromb Hemost 1990; 16:151.
Gerbasi FR, Bottoms S, Farag A, Mammen E. Increased intravascular coagulation associated with pregnancy. Obstet Gynecol 1990; 75:385.
Conard J, Horellou MH, Van Dreden P, Lecompte C, Samama M. Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women. Thromb Haemost 1990; 63:319.
Trauscht-Van Horn JJ, Capeless EL, Easterling TR, Bovill EG. Pregnancy loss and thrombosis with protein C deficiency. Am J Obstet Gynecol 1992; 167:968.
Letsky EA, Swiet M de. Thromboembolism in pregnancy and management. Br J Haematol 1984; 57:542.
Conard J, Horellou MH, Van Dreden P, Samama M. Pregnancy and congenital deficiency in antithrombin III or protein C. Thromb Haemost 1987; 58:39.
Bonnar J. Acute and chronic coagulation problem in pregnancy. In: Poller L, ed. Recent advances in blood coagulation. Edinburgh: Churchill Livingstone; 1977:363–378.
Weenink GH, Treffers PE, Kahle LH, Cate JW ten. Antithrombin III in normal pregnancy. Thromb Res 1982; 26:281.
Mannucci PM, Viganò S, Bottasso B, Candotti G, Bozzetti P, Rossi E, Pardi G. Protein C antigen during pregnancy, delivery and puerperium. Thromb Haemost 1984; 52:217.
Malm J, Laurell M, Dahlback B. Changes in the plasma levels of vitamin K-dependent protein C and S of C4b-binding protein during pregnancy and oral contraception. Br J Haematol 1988; 68:436.
Gonzales R, Alberca I, Vicente V. Protein C levels in late pregnancy and in women on oral contraceptives. Thromb Res 1985; 39:637.
Lao TT, Yuen PMP, Yin JA. Protein S and protein C levels in Chinese women during pregnancy, delivery and puerperium. Br J Obstet Gynaecol 1989; 96:167.
Comp PC, Thurnau GR, Welsh J, Esmon CT. Functional and immunologic protein S levels are decreased during pregnancy. Blood 1986; 68:881.
Gilabert J, Estelles A, Aznar J, Espana F, Andres C, Santos T, Valles J. Contribution of platelets to increased plasminogen activator inhibitor Type 1 in severe preeclampsia. Thromb Haemost 1990; 63:361.
Abrams C, Shattil SJ. Immunological detection of activated platelet in clinical disorders. Thromb Haemost 1991; 65:467.
Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987; 70:307.
Mannucci PM, Federici AB, Sirchia G. Hemostasis testing during massive blood replacement. Vox Sang 1982; 42:113.
Rossi E, Mondonico P, Lombardi A. Method for determination of functional fibrinogen by the new family of ACL coagulometers. Thromb Res 1988; 52:453.
Nicolini U, Guarneri D, Gianotti GA, Campagnoli C, Crosignani PG, Gatti L. Maternal and fetal platelet activation in normal pregnancy. Obstet Gynecol 1994; 83:65.
Rose PG, Essig GF, Vaccaro PS, Brand JT. Protein S deficiency in pregnancy. Am J Obstet Gynecol 1986; 155:140.
Preda L, Tripodi A, Valsecchi C, Lombardi A, Finotto E, Mannucci PM. A prothrombin time-based functional assay of protein S. Thromb Res 1990; 60:19.
Gershagen S, Fernlund P, Lundwall A. A cDNA coding for human sex hormone binding globulin. Homology to vitamin K-dependent protein S. FEBS Lett 1987; 220:129.
Boerger LM, Morris PC, Thurnan GR, Esmon CT, Comp PC. Oral contraceptives and gender affect protein S status. Blood 1987; 69:692.
Gilabert J, Fernandez JA, Espana F, Aznar J, Estelles A. Physiological coagulation inhibitors (protein S, protein C and antithrombin III) in severe preeclamptic states and in users of oral contraceptives. Thromb Res 1988; 49:319.
Rinder CS, Bohnert J, Rinder HM, Mitchell J, Ault K, Hillman R. Platelet activation and aggregation during cardiopulmonary by pass. Anesthesiology 1991; 75:388.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gatti, L., Tenconi, P.M., Guarneri, D. et al. Hemostatic parameters and platelet activation by flow-cytometry in normal pregnancy: a longitudinal study. Int J Clin Lab Res 24, 217–219 (1994). https://doi.org/10.1007/BF02592466
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02592466